Global Antitumor Antibiotics Market: Overview
Antitumor antibiotics are chemotherapy agents that work by altering the DNA inside cancerous cells. Unlike usual antibiotics, which are used to treat infections, antitumor antibiotics interfere with enzymes that are involved in copying DNA during the cell cycle. A major concern associated with antitumor antibiotics is that when given in high doses, these drugs can permanently damage the heart. As a result, lifetime dose limits are set for these drugs. Antitumor antibiotics are widely used in the management of a variety of cancers. Antibiotics that are used in chemotherapy act via different modes of action. Some antitumor antibiotics work as potent intercalating agents, whereas some act by damaging DNA. The discovery and development of DNA-specific drugs have shown enhanced efficacy compared to other drugs. This is anticipated to fuel the market during the forecast period.
Global Antitumor Antibiotics Market: Key Trends
The antitumor antibiotics market is estimated to be expand at a rapid pace in the next few years. The market is projected to be propelled by an increase in the prevalence of different types of cancer and strong research and development activities in the field of cancer therapeutics. Moreover, significant changes and modification in the parent chemical structures and introduction of newer classes of antibiotics are estimated to drive the market during the forecast period. The global burden of cancer is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018.
Global Antitumor Antibiotics Market: Segmentation
The antitumor antibiotics market can be segmented based on type of antibiotics, distribution channel, and region. Based on type of antibiotics, the market can be segmented into anthracyclines, chromomycin, and miscellaneous. The anthracyclines antibiotics segment can be further divided into doxorubicin, daunorubicin, epirubicin, mitoxantrone, and idarubicin. The chromomycins segment can be further categorized into dactinomycin and plicamycin. The miscellaneous segment can be divided into mitomycin and bleomycin. In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies.
Global Antitumor Antibiotics Market: Regional Analysis
Based on region, the antitumor antibiotics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account for a prominent share of the market in terms of revenue. Increase in research and development activities in the field of cancer therapeutics, high awareness among people about different diagnostic procedures, and rise in disposable income are some of the factors attributed to the high market share of the region. According to the National Cancer Institute, in the U.S., a rise in the incidence and prevalence of cancer has a major impact on the society across the world. According to their estimates, in 2018, more than 1.5 million people were expected to be diagnosed with cancer in the U.S.. Europe is expected to hold a prominent share of the market, owing to high awareness among people about treatment options, rise in the geriatric population, and high diagnosis rate of cancer in the region. The market in Asia Pacific is expected to expand at a rapid pace in the coming years. An increase in government initiatives in the field of health care, rise in the geriatric population, increase in disposable income, and increase in awareness among people are estimated to fuel the growth of the antitumor antibiotics market in the region.
Global Antitumor Antibiotics Market: Competitive Landscape
The global antitumor antibiotics market is highly fragmented due to the participation of many global as well as new players. Major players operating in the market are Amgen Inc., AG Scientific, Merck & Co, Inc., Pfizer Inc., Novartis International AG, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., and Astellas Pharma Inc..
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.